Session Chair Welcome | |||||
Wed30 Jun11:10am(5 mins)
|
Dr Michael Howell | Dr Sam Groom | |||
Session : Target ID & Validation | |||||
Room: Conference Room |
Using Genetics and Genomics to Drive Drug Discovery and Development | |||||
Wed30 Jun11:15am(25 mins)
|
Victor Neduva | ||||
Session : Target ID & Validation | |||||
Room: Conference Room |
Early identification of target candidates for pancreatic adenocarcinoma immunotherapy | |||||
Wed30 Jun11:40am(30 mins)
|
Dr Olaf Hardt | Dr Daniel Schäfer | |||
Session : Target ID & Validation | |||||
Room: Conference Room |
Hit and Run: a rapid route to new target ID with PROTEINi | |||||
Wed30 Jun12:10pm(25 mins)
|
Dr Benedict Cross | ||||
Session : Target ID & Validation | |||||
Room: Conference Room |
Streamlining Collaboration and Development for Neglected Disease Drug Discovery Using CDD Vault | |||||
Wed30 Jun12:35pm(15 mins)
|
Kelly Bachovchin | ||||
Session : Target ID & Validation | |||||
Room: Conference Room |
Identification of novel therapeutics for fibrotic diseases using phenotypic screening | |||||
Wed30 Jun02:30pm(20 mins)
|
Prof Selim Cellek | ||||
Session : Target ID & Validation | |||||
Room: Conference Room |
Single-cell CRISPR screens in primary human T cells | |||||
Wed30 Jun02:50pm(15 mins)
|
Dr Tilmann Buerckstuemmer | ||||
Session : Target ID & Validation | |||||
Room: Conference Room |